Stockscreener 앱 받기
263.73
1.00%
-2.24
전일 마감가:
$265.97
열려 있는:
$265.69
하루 거래량:
1.34M
Relative Volume:
0.21
시가총액:
$465.60B
수익:
$62.82B
순이익/손실:
$3.60B
주가수익비율:
130.08
EPS:
2.0274
순현금흐름:
$19.98B
1주 성능:
+4.98%
1개월 성능:
+3.92%
6개월 성능:
+17.13%
1년 성능:
+25.90%
1일 변동 폭
$262.72
$265.93
1주일 범위
$247.68
$266.96
52주 변동 폭
$190.75
$267.47
애브비 Stock (ABBV) Company Profile
명칭
Abbvie Inc
전화
(847) 932-7900
주소
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, MRK, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
263.48 | 470.00B | 62.82B | 3.60B | 19.98B | 2.0274 |
LLY
Lilly Eli Co
|
1,262.80 | 1.14T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
270.31 | 658.89B | 97.93B | 21.04B | 17.80B | 8.6278 |
MRK
Merck Co Inc
|
150.30 | 375.50B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
157.20 | 304.70B | 54.66B | 13.58B | 16.05B | 7.0171 |
애브비 Stock (ABBV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-30 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2026-04-21 | 개시 | Canaccord Genuity | Buy |
| 2026-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2026-02-20 | 개시 | Barclays | Overweight |
| 2026-01-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-10 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-11-04 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2025-10-14 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-10-01 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-09-17 | 업그레이드 | Berenberg | Hold → Buy |
| 2025-08-12 | 재개 | Piper Sandler | Overweight |
| 2025-08-07 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-05 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-04 | 업그레이드 | Argus | Hold → Buy |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-06-05 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-05-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-01-29 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-12-11 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-10-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 재개 | UBS | Neutral |
| 2023-09-29 | 개시 | Raymond James | Outperform |
| 2023-07-25 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-04-05 | 다운그레이드 | Argus | Buy → Hold |
| 2023-03-01 | 개시 | Guggenheim | Buy |
| 2023-02-22 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | 업그레이드 | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-11-08 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Underperform |
| 2022-05-06 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2022-02-28 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-03 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재확인 | Barclays | Equal Weight |
| 2022-02-03 | 재확인 | BofA Securities | Neutral |
| 2022-02-03 | 재확인 | Goldman | Neutral |
| 2022-01-13 | 개시 | Redburn | Buy |
| 2022-01-12 | 재확인 | BMO Capital Markets | Outperform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-11-23 | 업그레이드 | Societe Generale | Hold → Buy |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-06-23 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 업그레이드 | Argus | Hold → Buy |
| 2020-05-18 | 재개 | BofA/Merrill | Neutral |
| 2020-05-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 재개 | Morgan Stanley | Overweight |
| 2020-04-20 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 재확인 | Cowen | Outperform |
| 2019-09-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-08-20 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-04-29 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
모두보기
애브비 주식(ABBV)의 최신 뉴스
Vest Financial LLC Sells 3,946 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie stock hits fresh 52-week high as earnings strength and guidance lift outlook - Ad-hoc-news.de
AbbVie Inc. $ABBV Shares Sold by D.A. Davidson & CO. - MarketBeat
Benjamin Edwards Inc. Reduces Position in AbbVie Inc. $ABBV - MarketBeat
GUBRA: Biotech revenue normalized post-AbbVie deal; CRO rebounded with 11% growth and profitability - TradingView
GUBRA: Revenue fell sharply after last year's AbbVie deal, but pipeline and CRO growth continued - TradingView
AbbVie Raises $9 Billion Debt to Fund Acquisition - The Globe and Mail
AbbVie (NYSE:ABBV) Shares Up 2.6%What's Next? - MarketBeat
Is AbbVie Stock About To Break Out Again? - Yahoo Finance
HARMONY ASSET MANAGEMENT LLC's AbbVie Inc(ABBV) Holding History - GuruFocus
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - The Motley Fool
Billionaire Ken Griffin Increased His Position in This Dividend King by 547% - Yahoo Finance
Munich Reinsurance Co Stock Corp in Munich Has $39.59 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Insider Selling: AbbVie (NYSE:ABBV) EVP Sells 32,710 Shares - MarketBeat
AbbVie stock holds firm after Q2 revenue beat - Ad-hoc-news.de
Is AbbVie Inc (ABBV) Overvalued After 3.4% Rally? GF Value Says - GuruFocus
AbbVie Completes $10 Billion Senior Notes Offering to Support Apogee Therapeutics Acquisition - Kalkine Media
AbbVie completes $8.0 billion notes offering to support Apogee Therapeutics acquisition - Investing.com
AbbVie (NYSE:ABBV) Trading Up 3.5%Still a Buy? - MarketBeat
Form 8K AbbVie Inc For: 18 August By Investing.com - Investing.com UK
AbbVie completes $8.75B note offering to fund Apogee acquisition - TradingView
AbbVie (NYSE: ABBV) issues new senior notes with Apogee-linked redemption - Stock Titan
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
AbbVie Inc Stock (ABBV) Closed Up by 3.48% on Aug 18: Key Drivers Unveiled - TradingKey
Revance hires Janelle Wichmann as chief marketing officer of skincare unit - Fierce Pharma
AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support - Investing News Network
AbbVie Inc. $ABBV Shares Sold by Capital Investment Advisory Services LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by ABN Amro Investment Solutions - MarketBeat
Abundance Wealth Counselors Boosts Holdings in AbbVie Inc. $ABBV - MarketBeat
Wells Fargo raises Abbvie stock price target on HS drug potential - Investing.com Canada
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026? - AOL.com
Wells Fargo Adjusts Price Target on AbbVie to $300 From $295, Keeps Overweight Rating - marketscreener.com
AbbVie Inc. (ABBV) Stock Analysis: Navigating Growth With A 10.74% Potential Upside - DirectorsTalk Interviews
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings? - AOL.com
AbbVie Inc. $ABBV Shares Bought by Exchange Traded Concepts LLC - MarketBeat
Bellecapital International Ltd. Acquires 8,728 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Confluence Wealth Services Inc. - MarketBeat
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year - AOL.com
RWQ Financial Management Services Inc. Acquires 31,510 Shares of AbbVie Inc. $ABBV - MarketBeat
Mirae Asset Global Investments Co. Ltd. Has $124.56 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Campbell Newman Asset Management Inc. Sells 10,481 Shares of AbbVie Inc. $ABBV - MarketBeat
VIP Health Care Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
ABBV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
AbbVie (ABBV) Stock May Trade At A Premium Despite Cash Flow Upside - Yahoo Finance
SOA Wealth Advisors LLC. Sells 13,215 Shares of AbbVie Inc. $ABBV - MarketBeat
RWQ Financial Management Services, Inc.'s AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie Inc. $ABBV Stake Boosted by Envestnet Portfolio Solutions Inc. - MarketBeat
Kepler Cheuvreux (Suisse) SA's AbbVie Inc(ABBV) Holding History - GuruFocus
2 Reasons to Like ABBV and 1 to Stay Skeptical - Yahoo Finance
AbbVie Defends Its Turf, But Leaves One Big Question Open - Trefis
애브비 (ABBV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.30%
자본화:
|
볼륨(24시간):